Navigation Links
KGI Offers Mammalian Cell Culture Program for Biotech Industry Professionals
Date:9/18/2008

CLAREMONT, Calif., Sept. 18 /PRNewswire/ -- Keck Graduate Institute (KGI) today announced that it will conduct a five-day program for industry professionals to learn the latest developments in mammalian cell culture, from November 2-7, 2008.

"Mammalian cell biotechnology has undergone explosive growth over the last 25 years," said Matt Croughan, PhD, the George B. and Joy Rathmann Professor and director of the Amgen Bioprocessing Center at KGI. "There is strong demand for individuals skilled in mammalian cell biotechnology, and this new program will allow those in industry the opportunity to become more knowledgeable, operationally adept and business savvy about this growing field."

According to Croughan, recombinant Chinese hamster ovary (CHO) cells now surpass E Coli and all other expression systems for recombinant protein production, with total annual sales exceeding $30 billion. Amgen and Genentech make many of their products, including Enbrel(R) (arthritis), Aranesp(R) (kidney disease, anemia), Herceptin(R) (breast cancer) and Rituxan(R) (non-Hodgkin's lymphoma), from CHO cells.

The primary goal of the course is to provide an advanced background in mammalian cell biotechnology. The scientific, engineering and practical industrial aspects will be presented in a series of lectures and laboratory exercises held in the Amgen Bioprocessing Center at KGI. The lectures will cover a broad range of issues, from cell line engineering and design of culture medium to control of cell metabolism and operation of high density fed-batch cultures in large-scale bioreactors. In keeping with KGI's hands-on learning philosophy, the laboratory exercises will provide experience with many of the techniques and principles taught in that day's lectures. Course attendees will gain first-hand experience in setting up, running and analyzing data from high-density, fed-batch cultures in lab scale Applikon bioreactors.

Croughan was employed at Genentech fr
'/>"/>

SOURCE Keck Graduate Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ProSource 2.0 Offers Value, Savings for Lab Supplies
2. Friends of the Earth Report on Biofuel Production Offers Incomplete, Outdated and Inaccurate Picture, According to Brazilian Sugarcane Industry Association
3. Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment
4. GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza(R)
5. Spherics, Inc. Offers Once Daily Extended Release Formulation for Sustained and Stable Pramipexole Delivery
6. Minnesota Chiropractic Association Offers Backpack Safety Checklist
7. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
8. SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery
9. REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008
10. Facelift for Resumes Offers Hope for Job Seekers, says Resume Writing Service
11. Online Career Tool Offers Live Expert Advice Component
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich ... that the waiting period under the Hart-Scott-Rodino Antitrust ... acquisition expired on December 22, 2014, thereby completing ... requirement for the acquisition of the Company by ... antitrust clearance satisfies another condition to closing the ...
(Date:12/24/2014)... and NEW YORK , Dec. ... its open-label pilot study of mazindol in children with ... and Therapy in December 2014 . ... in children with attention deficit/hyperactivity disorder" ( Konofal et ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) shows that ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
(Date:12/22/2014)... CHAPEL HILL, N.C. , Dec. 22, 2014 ... ALNE) today announced that it has signed a ... biotechnology company that has developed and patented a ... and medical diagnostics products that enable rapid on-site ... and alcohol use/abuse and health issues in an ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5ALNE Announces Intention To Acquire BioTechPharma 2
... laboratory has found a way to turn common carbon ... with properties expected to prove useful in electronic, optical ... scientist Pulickel Ajayan, in collaboration with colleagues in China, ... one-step chemical process that is markedly simpler than established ...
... Jan. 12, 2012  LCA-Vision Inc. (NASDAQ: ... under the Lasik Plus ® brand, today announced that management ... on Tuesday, January 17, 2012, at 3:00 p.m. ... will be available at the Investor Relations section of LCA-Vision,s ...
... ANNAPOLIS, Md., Jan. 11, 2012 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, announced today that Eric I. ... Noble Financial Capital Markets Eighth Annual Equity Conference on Tuesday, ... Room/Room 2 at the Hard Rock Hotel, Hollywood Florida.  ...
Cached Biology Technology:Graphene quantum dots: The next big small thing 2Graphene quantum dots: The next big small thing 3PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012 2
(Date:12/10/2014)... 2014 CIE San Diego has launched an ... connective tissue that enhances care coordination among social service ... client-level information; earned a second $1 million grant from ... seniors aging in community and; will be recognized as ... th 4-6p. CIE San Diego today ...
(Date:12/10/2014)... 2014     ...   Jifflenow, a leading ... for business-to-business (B2B) events, today announced a partnership ... near-field communication (NFC), Bluetooth low energy (BLE), and ... , Jifflenow will integrate its meeting ...
(Date:12/5/2014)... 4, 2014  Tute Genomics, a leader in cloud-based ... Series A1 funding led by UK-based Eurovestech. Peak Ventures ... the investment round. "We are at a ... next-generation sequencing and seeks new approaches for the diagnosis, ... , MD MBA, and CEO of Tute Genomics. "One ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... the First World War, a lethal virus known as ... United States, Europe and Asia in three convulsive waves. ... to 100 million victims, most of whom succumbed to ... died within days of the first symptoms. ...
... ANDS ) announced today that it will present ... Monday, February 16, 2009 at 1:00 p.m. PST (4:00 p.m. ... Laguna Niguel. Steve Worland, Ph.D., President and Chief Executive Officer ... clinical programs: ANA598 and ANA773 in hepatitis C and ANA773 ...
... in eight women in the United States will receive a ... the second leading cause of cancer-related death in women. Now ... treatment for each patient. "Our research shows that there ... getting any treatment at all, other than a lumpectomy," explains ...
Cached Biology News:Shades of 1918? New study compares avian flu with a notorious killer from the past 2Shades of 1918? New study compares avian flu with a notorious killer from the past 3Shades of 1918? New study compares avian flu with a notorious killer from the past 4Shades of 1918? New study compares avian flu with a notorious killer from the past 5Anadys Pharmaceuticals to Present at the Roth OC Growth Stock Conference 2New test for breast cancer will help guide treatment choices 2
RayBio Human Atherosclerosis Antibody Array 1.1 (4) with Accessory, detects 40 inflammatory factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Catch and Release® v2.0 Reversible Immunoprecipitation System...
... Peptide-Protein Conjugation, Quantities to Kilograms, ... Peptides/Peptidomimetics, Special amino acids and ... Peptide labeling AMC, aldehyde, CMK, ... needs, Chromogenic/Flurogenic Substrates, Solid ...
5-bromouridine 5'-triphosphate (BrUTP) *10 mM in TE buffer*...
Biology Products: